The latest closing stock price for Xilio Therapeutics as of January 31, 2025 is 0.70.
An investor who bought $1,000 worth of Xilio Therapeutics stock at the IPO in 2021 would have $-956 today, roughly -1 times their original investment - a -64.68% compound annual growth rate over 3 years.
The all-time high Xilio Therapeutics stock closing price was 25.11 on November 16, 2021.
The Xilio Therapeutics 52-week high stock price is 1.93, which is 175.7% above the current share price.
The Xilio Therapeutics 52-week low stock price is 0.50, which is 28.6% below the current share price.
The average Xilio Therapeutics stock price for the last 52 weeks is 0.94.
An investor who bought $1,000 worth of Xilio Therapeutics stock at the IPO in 2021 would have $-956 today, roughly -1 times their original investment - a -64.68% compound annual growth rate over 3 years.
The all-time high Xilio Therapeutics stock closing price was 25.11 on November 16, 2021.
The Xilio Therapeutics 52-week high stock price is 1.93, which is 175.7% above the current share price.
The Xilio Therapeutics 52-week low stock price is 0.50, which is 28.6% below the current share price.
The average Xilio Therapeutics stock price for the last 52 weeks is 0.94.